Preparation of a Growth Hormone Receptor/Prolactin Receptor Bispecific Antibody Antagonist Which Exhibited Anti-Cancer Activity
Prolactin receptor (PRLR) and growth hormone receptor (GHR) are closely related to the occurrence and development of breast cancer, and breast cancer cell endogenously express GHR, PRLR and GHR-PRLR heterodimer. In this case, the combined use of PRLR or GHR inhibitors may produce better anti-breast...
Saved in:
Main Authors: | Xin Chen (Author), Di Wu (Author), Yan Zheng (Author), Xingxing Liu (Author), Jianmeng Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier
by: William M. Pardridge
Published: (2023) -
Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain
by: Denise Guerra, et al.
Published: (2024) -
Effects of deletion of the prolactin receptor on ovarian gene expression
by: Kelly Paul A, et al.
Published: (2003) -
The prolactin and growth hormone families: Pregnancy-specific hormones/cytokines at the maternal-fetal interface
by: Soares Michael J
Published: (2004) -
The curious case of prolactin hormone
by: Shaurya Rohatgi, et al.
Published: (2015)